Temodar and Atherosclerosis - a phase IV clinical study of FDA data

Summary:

Atherosclerosis is reported as a side effect among people who take Temodar (temozolomide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lorazepam, and have Brain oedema.

The phase IV clinical study analyzes which people have Atherosclerosis when taking Temodar. It is created by eHealthMe based on reports of 6,563 people who have side effects when taking Temodar from the FDA, and is updated regularly.

What is Temodar?

Temodar has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 6,683 Temodar users. Check the latest studies of Temodar.

What is Atherosclerosis?

Atherosclerosis (disorder of the arteries) is found to be associated with 1,209 drugs and 1,529 conditions by eHealthMe. Check the latest studies of Atherosclerosis.

On Jul, 16, 2026

6,563 people reported to have side effects when taking Temodar.
Among them, 14 people (0.21%) have Atherosclerosis.

Among these 14 people:

How long have people been on Temodar when they have Atherosclerosis? *

What is the gender of people who have Atherosclerosis when taking Temodar? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Atherosclerosis when taking Temodar? *

What are other drugs people take besides Temodar? *

What are other side effects people have besides Atherosclerosis? *

Thrombocytopenia (decrease of platelets in blood): 13 people, 92.86%
Depression: 12 people, 85.71%
Stress And Anxiety: 12 people, 85.71%
Atelectasis (partial or complete collapse of the lung): 12 people, 85.71%
Osteopenia (a condition where bone mineral density is lower than normal): 11 people, 78.57%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 11 people, 78.57%
Pleural Effusion (water on the lungs): 11 people, 78.57%
Hypokalemia (low potassium): 11 people, 78.57%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 11 people, 78.57%
Pain In Jaw: 11 people, 78.57%

What are the existing conditions these people have? *

Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 2 people, 14.29%
Stress And Anxiety: 1 person, 7.14%
Pulmonary Tuberculosis (lungs tuberculosis): 1 person, 7.14%
Pain: 1 person, 7.14%
Neoplasm Malignant (cancer tumour): 1 person, 7.14%
Histiocytosis Haematophagic: 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Depression: 1 person, 7.14%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Temodar and have Atherosclerosis?

- Check whether Atherosclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temodar:

Temodar (6,683 reports)

Atherosclerosis treatments and more:

Atherosclerosis (21,888 reports)

Browse all side effects of Temodar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atherosclerosis:

Atherosclerosis (1,209 drugs)

Browse all the conditions that are associated with Atherosclerosis:

Atherosclerosis (1,529 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temozolomide (the active ingredients of Temodar) and Temodar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.